{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:16:35Z","timestamp":1790388995504,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.diagmicrobio.2024.116539","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T06:59:52Z","timestamp":1726210792000},"page":"116539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cefiderocol as rescue therapy in a cancer immunosuppressed critically ill child: Case description and literature review"],"prefix":"10.1016","volume":"110","author":[{"given":"Juan","family":"A\u00f1\u00f3n-Hidalgo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Garrido-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Gonz\u00e1lez-Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Cuervas-Mons Vendrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Taida","family":"Garc\u00eda-Ascaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D\u00edaz P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8038-7430","authenticated-orcid":false,"given":"Alberto","family":"Garc\u00eda-Salido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.diagmicrobio.2024.116539_bib0001","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s10096-021-04288-1","article-title":"Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey","volume":"40","author":"El-Sokkary","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116539_bib0002","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/INF.0000000000001188","article-title":"Carbapenem-resistant enterobacteriaceae infections in children: an italian retrospective multicenter study","volume":"35","author":"Montagnani","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116539_bib0003","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116539_bib0004","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1038\/s41467-021-24448-3","article-title":"A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex","volume":"12","author":"Lam","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116539_bib0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/fpd.2020.2847","article-title":"Klebsiella pneumoniae: prevalence, reservoirs, antimicrobial resistance, pathogenicity, and infection: a hitherto unrecognized zoonotic bacterium","volume":"18","author":"Hu","year":"2021","journal-title":"Foodborne Pathog Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116539_bib0006","article-title":"[Position statement of the Spanish Association of Paediatrics-Spanish Society of Paediatric Infectious Diseases (AEP-SEIP) on the treatment of multidrug-resistant bacterial infections]","volume":"91","author":"Aguilera-Alonso","year":"2019","journal-title":"An Pediatr (Engl Ed)"},{"key":"10.1016\/j.diagmicrobio.2024.116539_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad428","article-title":"Infectious diseases society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116539_bib0008","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116539_bib0009","article-title":"The revival of aztreonam in combination with avibactam against metallo-beta-lactamase-producing gram-negatives: a systematic review of in vitro studies and clinical cases","volume":"10","author":"Mauri","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116539_bib0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41429-022-00537-3","article-title":"In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: role of combination drugs in antibiotic resistance era","volume":"75","author":"Sreenivasan","year":"2022","journal-title":"J Antibiot (Tokyo)"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116539_bib0011","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jac\/dkz468","article-title":"In vitro selection of aztreonam\/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae","volume":"75","author":"Niu","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116539_bib0012","doi-asserted-by":"crossref","first-page":"e1754","DOI":"10.1093\/cid\/ciaa1847","article-title":"Cefiderocol for the treatment of adult and pediatric patients with cystic fibrosis and achromobacter xylosoxidans infections","volume":"73","author":"Warner","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116539_bib0013","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jgar.2021.04.025","article-title":"Compassionate use of cefiderocol for VIM metallo-beta-lactamase-producing Pseudomonas aeruginosa infection in a toddler with Burkitt lymphoma","volume":"26","author":"Grasa","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116539_bib0014","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12098-022-04468-7","article-title":"Cefiderocol as salvage therapy for carbapenem-resistant klebsiella pneumoniae sepsis in an extremely preterm neonate","volume":"90","author":"Bawankule","year":"2023","journal-title":"Indian J Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2024.116539_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.37201\/req\/s01.07.2022","article-title":"Cefiderocol","volume":"35","author":"Soriano","year":"2022","journal-title":"Rev Esp Quimioter"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116539_bib0016","article-title":"Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.diagmicrobio.2024.116539_bib0017","unstructured":"AEMPS. Informe de Posicionamiento Terap\u00e9utico de cefiderocol (Fetcroja\u00ae) en el tratamiento de infecciones producidas por bacterias gramnegativas aerobias en pacientes adultos con opciones limitadas de tratamiento. 2023; https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/informesPublicos\/grupo-coordinacion-posicionamiento-terapeutico\/2020\/docs\/informa-reunion-CGPT-10-marzo.pdf. Accessed 2023, 2023."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2024.116539_bib0018","first-page":"S330","article-title":"739. Prediction of cefiderocol pharmacokinetics and probability of target attainment in pediatric subjects for proposing dose regimens","volume":"6","author":"Katsube","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116539_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101034","article-title":"Cefiderocol: clinical application and emergence of resistance","volume":"72","author":"Wang","year":"2024","journal-title":"Drug Resist Updat"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932400364X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932400364X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T04:45:57Z","timestamp":1740285957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288932400364X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S073288932400364X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116539","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefiderocol as rescue therapy in a cancer immunosuppressed critically ill child: Case description and literature review","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116539"}}